TABLE 26, [Subgroup analyses of SF-36 PCS score at 6 months according to baseline age and presenting complaint]. - A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of ‘PhysioDirect’ telephone assessment and advice services for physiotherapy

Subgroups at 6 months	SF-36v2 PCS	Randomisation– subgroup interaction^a^,^b	95% CI	p-value
Age (years)
18 to < 25	47.6	10.8	47.3	9.1	Ref.		0.59
25 to < 35	49.6	8.1	48.4	9.4	−0.04	−3.79 to 3.71
35 to < 45	47.1	10.7	45.7	9.5	−0.92	−4.54 to 2.70
45 to < 55	44.3	10.9	44.5	10.3	1.34	−2.29 to 4.97
55 to < 65	42.5	9.9	41.4	11.7	0.78	−2.79 to 4.35
65 to < 75	39.2	10.2	39.6	11.2	1.03	−2.74 to 4.79
75 to < 85	35.9	10.1	35.4	8.7	2.01	−2.45 to 6.47
85 to < 95	36.3	7.5	28.3	9.3	−2.67	−9.68 to 4.35
Site of problem
Cervical	43.8	9.9	42.7	10.5	Ref.		0.28
Thoracic	42.3	13.8	42.9	11.9	3.85	−4.00 to 1.70
Lumbar	44.1	10.9	42.2	10.5	1.35	−1.27 to 3.96
Upper limb	44.6	10.7	45.2	11.0	2.59	0.08 to 5.09
Lower limb	45.0	10.9	44.2	10.8	0.14	−2.32 to 2.59
Widespread pain	33.8	11.5	37.7	12.4	4.76	−3.88 to 3.40
Multiple MSK	39.4	11.4	40.7	13.2	2.61	−2.12 to 7.33
Other MSK	42.8	14.9	41.1	14.2	3.39	−5.29 to 12.07

Subgroups at 6 months

SF-36v2 PCS

Randomisation– subgroup interaction^a^,^b

95% CI

p-value

Usual care

PhysioDirect

Mean

Age (years)

18 to < 25

47.6

10.8

47.3

9.1

Ref.

0.59

25 to < 35

49.6

8.1

48.4

9.4

−0.04

−3.79 to 3.71

35 to < 45

47.1

10.7

45.7

9.5

−0.92

−4.54 to 2.70

45 to < 55

44.3

10.9

44.5

10.3

1.34

−2.29 to 4.97

55 to < 65

42.5

9.9

41.4

11.7

0.78

−2.79 to 4.35

65 to < 75

39.2

10.2

39.6

11.2

1.03

−2.74 to 4.79

75 to < 85

35.9

10.1

35.4

8.7

2.01

−2.45 to 6.47

85 to < 95

36.3

7.5

28.3

9.3

−2.67

−9.68 to 4.35

Site of problem

Cervical

43.8

9.9

42.7

10.5

Ref.

0.28

Thoracic

42.3

13.8

42.9

11.9

3.85

−4.00 to 1.70

Lumbar

44.1

10.9

42.2

10.5

1.35

−1.27 to 3.96

Upper limb

44.6

10.7

45.2

11.0

2.59

0.08 to 5.09

Lower limb

45.0

10.9

44.2

10.8

0.14

−2.32 to 2.59

Widespread pain

33.8

11.5

37.7

12.4

4.76

−3.88 to 3.40

Multiple MSK

39.4

11.4

40.7

13.2

2.61

−2.12 to 7.33

Other MSK

42.8

14.9

41.1

14.2

3.39

−5.29 to 12.07

From: Chapter 3, Randomised controlled trial: results

Cover of A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of ‘PhysioDirect’ telephone assessment and advice services for physiotherapy

A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of ‘PhysioDirect’ telephone assessment and advice services for physiotherapy.

Health Technology Assessment, No. 17.2.

Salisbury C, Foster NE, Hopper C, et al.

Southampton (UK): NIHR Journals Library; 2013 Jan.

Copyright © Queen's Printer and Controller of HMSO 2013. This work was produced by Salisbury et al. under the terms of a commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.

Included under terms of UK Non-commercial Government License.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.